This important study used five metrics to compare the cost-effectiveness of intramural and extramural research funded by the National Institutes of Health in the United States between 2009 and 2019.
Survivors of high-risk neuroblastoma treated with modern therapies demonstrated a substantial burden of late effects, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback